[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100463472":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":29,"centralContacts":33,"locations":43,"responsibleParty":61,"collaborators":64,"id":71,"slug":10,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":10,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":10,"maxAge":10,"enrollmentInfo":78,"targetDuration":81,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Xiangya Hospital of Central South University","OTHER",[8,13,16,19,22],{"label":9,"type":10,"description":10,"interventionNames":11},"Xiangya Hospital",null,[12],"Other: No Intervention",{"label":14,"type":10,"description":10,"interventionNames":15},"The Second Xiangya Hospital",[12],{"label":17,"type":10,"description":10,"interventionNames":18},"The Third Xiangya Hospital",[12],{"label":20,"type":10,"description":10,"interventionNames":21},"Hunan Provincial People's Hospital",[12],{"label":23,"type":10,"description":10,"interventionNames":24},"Xiangtan Central Hospital",[12],[26],{"type":6,"name":27,"description":27,"armGroupLabels":28,"otherNames":10},"No Intervention",[20,14,17,23,9],[30],{"name":31,"affiliation":5,"role":32},"Xiangcheng Xiao, doctor","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":38},"Yong Zhong, doctor","CONTACT","+86073189753025","zhongyong121@163.com",{"name":40,"role":36,"phone":41,"phoneExt":10,"email":42},"Ting Meng, doctor","+86073184327431","mengting252@163.com",[44],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Xiangya hospital","RECRUITING","Changsha","Hunan","410008","China","CN",{"type":53,"coordinates":54},"Point",[55,56],112.97087,28.19874,{"lat":56,"lon":55},[59,60],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":38},{"name":40,"role":36,"phone":41,"phoneExt":10,"email":42},{"type":32,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Xiangcheng Xiao","Professor",[65,67,69,70],{"name":66,"class":6},"Central South University",{"name":68,"class":6},"The Third Xiangya Hospital of Central South University",{"name":20,"class":6},{"name":23,"class":6},"100463472",false,"NCT05315141","Multicenter Cohort Study of AAV in Hunan of China","Multicenter Cohort Study of ANCA-associated Small Vasculitis in Hunan Province of China","Inclusion Criteria:\n\n* Fulfill 2012 criteria of ANCA associated vasculitis and agree to sign informed consent\n\nExclusion Criteria:\n\n* Do not agree to sign informed consent","ALL",{"count":79,"type":80},500,"ESTIMATED","5 Years","OBSERVATIONAL","This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.",[85],"ANCA Associated Vasculitis",[85,87,88],"ESRD","Outcome","2022-04-06",{"date":91,"type":92},"2022-04-07","ACTUAL",{"date":94,"type":92},"2022-03-16",{"date":96,"type":80},"2027-03-16",{"name":5,"class":6},1]